Get the Stockscreener App
1.45
1.40%
0.02
NanoViricides Inc stock is traded at $1.45, with a volume of 85,157.
It is up +1.40% in the last 24 hours and down -5.84% over the past month.
NanoViricides, Inc., a nano-biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of viral infections. The company is developing anti-influenza drug candidates at pre-clinical and advanced pre-clinical stage, which include two FluCide drugs, such as NV-INF-2, an oral anti-influenza drug and NV-INF-1, an injectable anti-influenza drug for H7N9, Bird Flu H5N1, and other Highly Pathogenic Influenzas; and HIVCide, an anti-human immunodeficiency virus (HIV) drug candidate that could provide functional cure for HIV/AIDS. It is also developing HerpeCide, a skin cream or gel formulation for the treatment of oral and genital herpes virus infections; and eye drops against viral infections of the external eye, as well as involved in the other research programs against Rabies virus, Ebola, and Marburg viruses. NanoViricides, Inc. was founded in 2005 and is based in Shelton, Connecticut.
See More
Previous Close:
$1.43
Open:
$1.42
24h Volume:
85,157
Relative Volume:
0.41
Market Cap:
$23.30M
Revenue:
-
Net Income/Loss:
$-8.29M
P/E Ratio:
-2.0714
EPS:
-0.7
Net Cash Flow:
$-6.47M
1W Performance:
-2.68%
1M Performance:
-5.84%
6M Performance:
+17.89%
1Y Performance:
-13.69%
1-Day Range:
$1.41
$1.4599
1-Week Range:
$1.41
$1.49
52-Week Range:
$0.94
$1.9195
NanoViricides Inc Stock (NNVC) Company Profile
Name
NanoViricides Inc
Sector
Industry
Phone
203-937-6137
Address
1 Controls Drive, Shelton, CT
Compare NNVC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NNVC
NanoViricides Inc
|
1.45 | 22.98M | 0 | -8.29M | -6.47M | -0.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
NanoViricides Inc Stock (NNVC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-11-15 | Initiated | Midtown Partners | Strong Buy |
NanoViricides Inc Stock (NNVC) Latest News
Top chart patterns to watch in NanoViricides Inc.2025 Dividend Review & Free Real-Time Market Sentiment Alerts - Newser
Statistical indicators supporting NanoViricides Inc.’s strength2025 Market Outlook & Daily Volume Surge Trade Alerts - Newser
Will NanoViricides Inc. outperform the marketWatch List & Fast Entry Momentum Alerts - Newser
Risk vs reward if holding onto NanoViricides Inc.Gap Up & Real-Time Buy Signal Alerts - Newser
NanoViricides Inc. stock outlook for YEAR2025 Retail Activity & Daily Profit Focused Stock Screening - Newser
What earnings revisions data tells us about NanoViricides Inc.Rate Hike & Risk Managed Investment Entry Signals - Newser
Will NanoViricides Inc. stock recover after recent dropMarket Volume Summary & Real-Time Buy Zone Alerts - Newser
Is this a good reentry point in NanoViricides Inc.Weekly Risk Summary & Fast Exit/Entry Strategy Plans - Newser
Heatmap analysis for NanoViricides Inc. and competitorsJuly 2025 Closing Moves & Low Risk Investment Opportunities - Newser
Is NanoViricides Inc. stock bottoming outJuly 2025 Snapshot & Capital Efficient Trading Techniques - Newser
Ranking NanoViricides Inc. among high performing stocks via toolsAnalyst Upgrade & Scalable Portfolio Growth Methods - Newser
Short interest data insights for NanoViricides Inc.July 2025 PreEarnings & AI Enhanced Trade Execution Alerts - Newser
Multi asset correlation models including NanoViricides Inc.Portfolio Gains Report & Community Driven Trade Alerts - Newser
Pattern recognition hints at NanoViricides Inc. upside2025 Market WrapUp & Free Technical Confirmation Trade Alerts - Newser
Why NanoViricides Inc. is moving todayRecession Risk & Trade Opportunity Analysis - Newser
Historical volatility pattern of NanoViricides Inc. visualizedWeekly Gains Summary & Long-Term Capital Growth Ideas - Newser
NanoViricides Inc. stock trendline breakdownMarket Trend Report & Growth Focused Entry Reports - Newser
Using economic indicators to assess NanoViricides Inc. potential2025 Technical Patterns & Free Community Supported Trade Ideas - Newser
NanoViricides Inc. stock retracement – recovery analysisEarnings Beat & AI Enhanced Trading Signals - Newser
Should you wait for a breakout in NanoViricides Inc.Trade Ideas & Technical Pattern Based Signals - Newser
Signal strength of NanoViricides Inc. stock in tech scannersJuly 2025 Analyst Calls & AI Enhanced Trading Signals - Newser
NanoViricides to Present at the Life Science Executive Partnering (LSX) Congress in Boston on September 17, 2025 - Livingston Daily
RETRANSMISSION: NanoViricides to Present at the Life Science Executive Partnering (LSX) Congress in Boston on September 17, 2025 - Weatherford Democrat
What institutional flow reveals about NanoViricides Inc.2025 Price Targets & Capital Protection Trade Alerts - Newser
Market reaction to NanoViricides Inc.’s recent newsJuly 2025 Weekly Recap & Reliable Volume Spike Trade Alerts - Newser
Sector ETF performance correlation with NanoViricides Inc.July 2025 Intraday Action & Community Consensus Stock Picks - Newser
NanoViricides to Present Broad-Spectrum Antiviral Platform at LSX World Congress 2025 - citybuzz -
NanoViricides (NYSE:NNVC) Trading 1.4% Higher – Still a Buy? - Defense World
Real time breakdown of NanoViricides Inc. stock performanceMarket Volume Report & High Accuracy Trade Signal Alerts - Newser
Key resistance and support levels for NanoViricides Inc.2025 Key Highlights & Entry Point Confirmation Alerts - Newser
nanoviricides inc. stock retracement – recovery analysis2025 Short Interest & Reliable Momentum Entry Alerts - Newser
Order flow analysis tools used on NanoViricides Inc.Market Risk Summary & Daily Profit Focused Stock Screening - Newser
Technical signs of recovery in NanoViricides Inc.July 2025 News Drivers & Smart Money Movement Alerts - Newser
NanoViricides Inc Stock (NNVC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):